AMPICILLIN- ampicillin sodium injection, powder, for solution

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

AMPICILLIN SODIUM (UNII: JFN36L5S8K) (AMPICILLIN - UNII:7C782967RD)

Доступна з:

Sandoz GmbH

Адміністрація маршрут:

INTRAVENOUS

Тип рецепту:

PRESCRIPTION DRUG

Терапевтичні свідчення:

Ampicillin for Injection, USP is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: Respiratory Tract Infections caused by Streptococcus pneumoniae . Staphylococcus aureus (penicillinase and nonpenicillinase-producing), H. influenzae, and Group A beta-hemolytic Streptococci . Bacterial Meningitis caused by E. coli, Group B Streptococci , and other Gram-negative bacteria (Listeria monocytogenes, N. meningitidis ). The addition of an aminoglycoside with ampicillin may increase its effectiveness against Gram-negative bacteria. Septicemia and Endocarditis caused by susceptible Gram-positive organisms including Streptococcus spp., penicillin G-susceptible staphylococci, and enterococci . Gram-negative sepsis caused by E. coli, Proteus mirabilis and Salmonella sp. respond to ampicillin. Endocarditis due to enterococcal strains usually respond to intravenous therapy. The addition of an aminoglycoside may enhance the effectiveness

Огляд продуктів:

Ampicillin for Injection, USP ADD-Vantage® for intravenous injection. Ampicillin sodium equivalent to 1 or 2 grams ampicillin per vial. NDC 43858-123-92 1 gram ADD-Vantage® Vial, packed in 10s NDC 43858-124-92 2 grams ADD-Vantage® Vial, packed in 10s Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

Статус Авторизація:

Abbreviated New Drug Application

Характеристики продукта

AMPICILLIN- AMPICILLIN SODIUM INJECTION, POWDER, FOR SOLUTION
SANDOZ GMBH
----------
AMPICILLIN FOR INJECTION, USP
FOR INTRAVENOUS INJECTION ONLY
IN ADD-VANTAGE® DRUG DELIVERY SYSTEM
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of ampicillin and
other antibacterial drugs, ampicillin should be used only to treat or
prevent infections that are proven or
strongly suspected to be caused by bacteria.
DESCRIPTION
Ampicillin for Injection, USP the monosodium salt of
[2S-[2α,5α,6β(S*)]]-6-
[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic
acid, is
a synthetic penicillin. It is an antibacterial agent with a broad
spectrum of bactericidal activity against
both penicillin-susceptible Gram-positive organisms and many common
Gram-negative pathogens.
Ampicillin for Injection, USP is a white to cream-tinged, crystalline
powder. The reconstituted solution
is clear, colorless and free from visible particulates.
Each ADD-Vantage
vial of Ampicillin for Injection, USP contains ampicillin sodium
equivalent to 1
gram or 2 grams ampicillin. Ampicillin for Injection, USP contains 2.9
milliequivalents of sodium per
gram of ampicillin.
It has the following molecular structure:
The molecular formula is C
H N NaO S, and the molecular weight is 371.39. The pH range of the
reconstituted solution is 8 to 10.
CLINICAL PHARMACOLOGY
Ampicillin for Injection, USP diffuses readily into most body tissues
and fluids. However, penetration
into the cerebrospinal fluid and brain occurs only when the meninges
are inflamed. Ampicillin is
excreted largely unchanged in the urine and its excretion can be
delayed by concurrent administration of
probenecid. Due to maturational changes in renal function, ampicillin
half-life decreases as
postmenstrual age (a sum of gestational age and postnatal age)
increases for infants with postnatal age of
less than 28 days. The active form appears in the bile in higher
concentrations than those found in
®
16
18
3
4
serum. Ampicillin is th